A review of the literature for all 53 named genes in Tables 2 identified 25 genes whose products have been demonstrated to function in cytokine, tumor necrosis factor, or T cell receptor signaling, or complement function.
|
|
| Figure2: A subset
of genes with significantly higher expression in rituximab responders versus
non-responders are listed by biological function. A review of the literature for all 53 named genes in Tables 2 identified 25 genes whose products have been demonstrated to function in cytokine, tumor necrosis factor, or T cell receptor signaling, or complement function. |